What is the latest ALBERTDAVD stock price?
The latest stored price for ALBERTDAVD is Rs 833.60 as of 2026-09-18.
gimli
ALBERTDAVD stock AI analysis
ALBERTDAVD Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ALBERT DAVID LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available ALBERTDAVD price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹833.60
1W return
-1.93%
1M return
+0.07%
3M return
+17.10%
6M return
+23.86%
1Y return
+2.82%
Market cap
₹475.75 cr
PE
21.08
PB
1.22
ROE
+5.76%
ROCE
-1.41%
RSI
48.99
Turnover
₹0.15 cr
Why it can matter in screens
- Momentum: ALBERTDAVD is above 50DMA, above 200DMA; RSI is 48.99.
- Returns: 1D -0.58%, 1W -1.93%, 1M +0.07%, 3M +17.10%, 1Y +2.82%.
- Trend levels: 52W high ₹931.85, 52W low ₹678.00, off high -10.54%.
- Liquidity: latest turnover is ₹0.15 cr; volume vs 20D is +0.25%.
- Valuation/profitability: PE 21.08, PB 1.22, ROE +5.76%, ROCE -1.41%.
- Growth: 3Y sales CAGR -0.63%, 3Y profit CAGR n/a.
Quick Answers
Is ALBERTDAVD above its 50DMA and 200DMA?
ALBERTDAVD is above 50DMA, above 200DMA. The latest 50DMA is 786.84 and the latest 200DMA is 733.41.
What are ALBERTDAVD PE, ROE and ROCE?
ALBERTDAVD has PE 21.08, ROE +5.76%, and ROCE -1.41% in Gimli's latest available snapshot.
How has ALBERTDAVD performed recently?
ALBERTDAVD has returned +0.07% over 1 month, +17.10% over 3 months, and +2.82% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 129.30 cr | 38.60 cr | 32.00 cr | 56.07 |
| 2026-03-31 | 85.86 cr | -22.08 cr | -21.43 cr | -37.56 |
| 2025-12-31 | 89.93 cr | 23.22 cr | 15.30 cr | 26.81 |
| 2025-09-30 | 87.24 cr | 0.40 cr | -3.30 cr | -5.79 |
| 2025-06-30 | 70.57 cr | 11.38 cr | 7.94 cr | 13.91 |
| 2025-03-31 | 74.89 cr | -9.86 cr | -10.33 cr | -18.10 |
| 2024-12-31 | 83.08 cr | -8.34 cr | n/a | nan |
| 2024-09-30 | 98.44 cr | 26.86 cr | n/a | 31.67 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 333.60 cr | 12.92 cr | -1.49 cr | -2.62 |
| 2025-03-31 | 345.77 cr | 32.61 cr | 17.20 cr | 30.14 |
| 2024-03-31 | 360.26 cr | 104.32 cr | 75.42 cr | 132.15 |
| 2023-03-31 | 340.01 cr | 59.62 cr | 36.17 cr | 63.39 |
| 2022-03-31 | 329.35 cr | 56.50 cr | 35.26 cr | 61.78 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 519.13 cr | 0.30 cr | 29.58 cr | 391.54 cr |
| 2025-03-31 | 511.42 cr | 0.42 cr | 12.32 cr | 392.48 cr |
| 2024-03-31 | 497.99 cr | 5.44 cr | 3.32 cr | 382.98 cr |
| 2023-03-31 | 423.39 cr | 1.45 cr | 5.32 cr | 311.57 cr |
| 2022-03-31 | 401.23 cr | 2.28 cr | 5.66 cr | 279.47 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -7.66 cr | -36.77 cr | n/a |
| 2025-03-31 | -28.44 cr | -43.29 cr | n/a |
| 2024-03-31 | 45.50 cr | 34.63 cr | n/a |
| 2023-03-31 | 10.52 cr | 5.28 cr | n/a |
| 2022-03-31 | 40.41 cr | 29.33 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +62.24% | +0.57% | +1.64% | +0.01% | +35.56% | +0.00% |
| 2026-03-31 | +62.24% | +0.58% | +1.66% | +0.01% | +35.52% | +0.00% |
| 2025-12-31 | +62.24% | +0.60% | +1.66% | +0.01% | +35.50% | +0.00% |
| 2025-09-30 | +62.24% | +0.60% | +1.66% | +0.01% | +35.50% | +0.00% |
| 2025-06-30 | +62.24% | +0.84% | +1.66% | +0.01% | +35.26% | +0.00% |
| 2025-03-31 | +62.24% | +1.01% | +1.65% | +0.01% | +35.11% | +0.00% |
| 2024-12-31 | +62.13% | +0.86% | +1.64% | +0.01% | +35.37% | +0.00% |
| 2024-09-30 | +62.13% | +0.88% | +1.64% | +0.01% | +35.35% | +0.00% |
| 2024-06-30 | +62.13% | +0.80% | +1.67% | +0.01% | +35.40% | +0.00% |
| 2024-03-31 | +62.13% | +0.98% | +1.67% | +0.01% | +35.22% | +0.00% |
| 2023-12-31 | +62.04% | +0.70% | +1.67% | +0.01% | +35.59% | +0.00% |
| 2023-09-30 | +62.04% | +0.57% | +1.90% | +0.01% | +35.48% | +0.00% |
| 2023-06-30 | +62.04% | +0.65% | +2.30% | +0.01% | +35.01% | +0.00% |
| 2023-03-31 | +62.04% | +0.57% | +2.80% | +0.01% | +34.59% | +0.00% |
| 2022-12-31 | +61.99% | +0.57% | +2.84% | +0.01% | +34.59% | +0.00% |
| 2022-09-30 | +61.99% | +0.61% | +2.98% | +0.01% | +34.42% | n/a |
| 2022-06-30 | +61.99% | +0.00% | +3.81% | n/a | n/a | +0.00% |
| 2022-03-31 | +61.96% | +0.00% | +3.93% | n/a | n/a | +0.00% |
| 2021-12-31 | +61.64% | +0.00% | +3.89% | n/a | n/a | +0.00% |
| 2021-09-30 | +61.35% | +0.00% | +3.68% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze ALBERT DAVID with valuation, momentum and industry peers
- Compare ALBERTDAVD with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ALBERTDAVD with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.